PATIENT SATISFACTION AND SENSORY ATTRIBUTES OF TWO COMBINATION NASAL SPRAYS (OLOPATADINE HYDROCHLORIDE/MOMETASONE FUROATE MONOHYDRATE AND AZELASTINE HYDROCHLORIDE/FLUTICASONE PROPIONATE) FOR TREATMENT OF ALLERGIC RHINITIS IN AUSTRALIA

被引：0
|
作者：
Fifer, Simon [1 ]
Toh, Lili [1 ]
Young, Katherine [2 ]
Morgan, Claire [2 ]
Aggarwal, Vineet [3 ]
Borade, Dhammraj [3 ]
Gordonsmith, Roger [4 ]
Wu, Wen [3 ]
机构：
[1] Community & Patient Preference Res CaPPRe, Sydney, NSW, Australia
[2] Seqirus Pty Ltd, Parkville, Vic, Australia
[3] Glenmark Pharmaceut Ltd, Mumbai, Maharashtra, India
[4] Glenmark Pharmaceut Europe, Watford, England
来源：
INTERNAL MEDICINE JOURNAL | 2022年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P55
引用
收藏
页码：18 / 19
页数：9
相关论文
共 40 条
  • [31] Preferences of adult patients with allergic rhinitis for the sensory attributes of fluticasone furoate versus fluticasone propionate nasal sprays: A randomized, multicenter, double-blind, single-dose, crossover study
    Meltzer, Eli O.
    Stahlman, Jon E.
    Leflein, Jeffrey
    Meltzer, Steven
    Lim, Junghee
    Dalal, Anand A.
    Prillaman, Barbara A.
    Philpot, Edward E.
    CLINICAL THERAPEUTICS, 2008, 30 (02) : 271 - 279
  • [32] A BUDGET IMPACT ANALYSIS OF AZELASTINE HYDROCHLORIDE/FLUTICASONE PROPIONATE (AZEFLU) NASAL SPRAY SUSPENSION FOR PATIENTS WITH ALLERGIC RHINITIS (AR) IN THE KINGDOM OF SAUDI ARABIA
    Agarwal, J.
    Alruthia, Y.
    Kopietz, F.
    Kumar, R.
    Thompson, R.
    VALUE IN HEALTH, 2024, 27 (12)
  • [33] MP29-02 (Intranasal Formulation of Azelastine Hydrochloride and Fluticasone Propionate) in the Treatment of Ocular Symptoms of Seasonal Allergic Rhinitis (SAR)
    Ratner, P.
    Meltzer, E. O.
    Carr, W.
    Ginsberg, D.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB134 - AB134
  • [34] A Randomized Control Trail of Stepwise Treatment with Fluticasone Propionate Nasal Spray and Fexofenadine Hydrochloride Tablet for Seasonal Allergic Rhinitis
    Takahashi, Goro
    Matsuzaki, Zensei
    Okamoto, Atsushi
    Ito, Eiko
    Matsuoka, Tomokazu
    Nakayama, Takeo
    Masuyama, Keisuke
    ALLERGOLOGY INTERNATIONAL, 2012, 61 (01) : 155 - 162
  • [35] Comparative study of the efficacy and safety of intranasal azelastine hydrochloride and fluticasone furoate in the treatment of allergic rhinitis (vol 27, pg186, 2020)
    Chennakeshavaraju, N.
    Narayana, S.
    Mohiyuddin, M. A. S.
    JOURNAL OF FAMILY AND COMMUNITY MEDICINE, 2021, 28 (01): : 65 - 65
  • [36] Efficacy of a Novel Intranasal Formulation of Azelastine Hydrochloride and Fluticasone Propionate, Delivered in a Single Spray, for the Treatment of Seasonal Allergic Rhinitis: Results from Russia
    Ilyina, Natalia I.
    Edin, Anton S.
    Astafieva, Natalia G.
    Lopatin, Andrey S.
    Sidorenko, Irina V.
    Ukhanova, Olga P.
    Khanova, Fatimat M.
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2019, 178 (03) : 255 - 263
  • [37] Comparison of patient preference for sensory attributes of fluticasone furoate or fluticasone propionate in adults with seasonal allergic rhinitis: a randomized, placebo-controlled, double-blind study
    Meltzer, Eli O.
    Andrews, Charles
    Journeay, Glen E.
    Lim, Junghee
    Prillaman, Barbara A.
    Garris, Cindy
    Philpot, Edward
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2010, 104 (04) : 331 - 338
  • [38] A Clinical Study to Assess the Efficacy and Safety of MP-AzeFlu Nasal Spray in Comparison to Commercially Available Azelastine Hydrochloride and Fluticasone Propionate Nasal Sprays in Chinese Volunteers with Allergic Rhinitis (vol 9, pg 411, 2023)
    Zhou, Bing
    Cheng, Lei
    Pan, Jing
    Wang, Huizhong
    Jin, Yongde
    Zhao, Changqing
    Lin, Peng
    Tan, Guolin
    Fang, Hongyan
    Zhang, Hua
    Zhou, Huifang
    Dong, Yaowu
    Kuhl, Hans Christian
    Ramalingam, Rajesh Kumar
    Nguyen, Duc Tung
    PULMONARY THERAPY, 2024, 10 (01) : 143 - 144
  • [39] Advances in pharmacotherapy for the treatment of allergic rhinitis; MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gaps
    Bousquet, Jean
    Bachert, Claus
    Bernstein, Jonathan
    Canonica, G. Walter
    Carr, Warner
    Dahl, Ronald
    Demoly, Pascal
    Devillier, Philippe
    Hellings, Peter
    Fokkens, Wytske
    Klimek, Ludger
    Lieberman, Phil
    Meltzer, Eli
    Price, David
    Ryan, Dermot
    Wahn, Ulrich
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (06) : 913 - 928
  • [40] MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: A randomized, double-blind, placebo-controlled trial of efficacy and safety
    Meltzer, Eli O.
    LaForce, Craig
    Ratner, Paul
    Price, David
    Ginsberg, David
    Carr, Warner
    ALLERGY AND ASTHMA PROCEEDINGS, 2012, 33 (04) : 324 - 332
1234